tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Ratios

Compare
680 Followers

Ascendis Pharma Ratios

ASND's free cash flow for Q3 2025 was €0.90. For the 2025 fiscal year, ASND's free cash flow was decreased by € and operating cash flow was €-0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.03 1.17 3.56 5.39 8.03
Quick Ratio
0.73 0.84 2.50 4.63 7.28
Cash Ratio
0.55 0.62 1.99 2.60 4.45
Solvency Ratio
-0.16 -0.28 -0.48 -0.68 -1.83
Operating Cash Flow Ratio
-0.11 -0.34 -2.37 -2.89 -4.16
Short-Term Operating Cash Flow Coverage
-0.22 -0.62 -41.63 -42.62 -59.71
Net Current Asset Value
€ -311.04M€ -224.34M€ -268.56M€ 97.08M€ 604.60M
Leverage Ratios
Debt-to-Assets Ratio
0.70 0.73 0.78 0.47 0.10
Debt-to-Equity Ratio
-4.67 -8.10 -4.42 1.93 0.12
Debt-to-Capital Ratio
1.27 1.14 1.29 0.66 0.11
Long-Term Debt-to-Capital Ratio
2.11 1.41 1.37 0.60 0.00
Financial Leverage Ratio
-6.63 -11.16 -5.67 4.14 1.23
Debt Service Coverage Ratio
-0.28 -0.53 -7.57 -9.04 -38.81
Interest Coverage Ratio
-6.88 -4.26 -10.34 -11.13 -115.52
Debt to Market Cap
0.07 0.11 0.09 0.06 <0.01
Interest Debt Per Share
13.69 15.93 12.23 9.97 1.99
Net Debt to EBITDA
-2.06 -1.02 -0.61 -0.11 0.81
Profitability Margins
Gross Profit Margin
86.80%87.83%83.36%76.28%54.71%
EBIT Margin
-23.28%-84.63%-161.25%-1069.17%-4886.00%
EBITDA Margin
-20.60%-79.76%-154.16%-1086.57%-5447.00%
Operating Profit Margin
-22.55%-76.66%-170.79%-1097.85%-5808.59%
Pretax Profit Margin
-34.54%-102.64%-177.77%-1129.12%-4936.28%
Net Profit Margin
-36.03%-103.97%-180.51%-1139.63%-4931.56%
Continuous Operations Profit Margin
-36.03%-103.97%-180.51%-1139.63%-4931.56%
Net Income Per EBT
104.30%101.30%101.54%100.93%99.90%
EBT Per EBIT
153.19%133.89%104.08%102.85%84.98%
Return on Assets (ROA)
-20.17%-32.05%-58.32%-53.52%-35.36%
Return on Equity (ROE)
141.79%357.68%330.44%-221.45%-43.41%
Return on Capital Employed (ROCE)
-86.64%-102.63%-72.51%-61.17%-45.89%
Return on Invested Capital (ROIC)
-22.41%-36.53%-70.77%-60.08%-45.20%
Return on Tangible Assets
-20.24%-32.16%-58.63%-53.76%-35.53%
Earnings Yield
-1.92%-4.91%-7.51%-9.12%-5.92%
Efficiency Ratios
Receivables Turnover
4.80 2.19 4.78 4.30 3.54
Payables Turnover
1.09 0.46 0.47 0.12 0.06
Inventory Turnover
0.28 0.15 0.21 0.09 0.05
Fixed Asset Turnover
6.35 3.68 2.41 0.40 0.06
Asset Turnover
0.56 0.31 0.32 0.05 <0.01
Working Capital Turnover Ratio
26.25 6.10 0.42 0.07 0.01
Cash Conversion Cycle
1.03K 1.81K 1.02K 976.35 1.76K
Days of Sales Outstanding
76.06 166.90 76.32 84.95 103.24
Days of Inventory Outstanding
1.29K 2.44K 1.72K 3.93K 7.81K
Days of Payables Outstanding
336.17 794.97 777.49 3.04K 6.16K
Operating Cycle
1.37K 2.60K 1.79K 4.01K 7.92K
Cash Flow Ratios
Operating Cash Flow Per Share
-1.75 -5.29 -8.30 -8.84 -7.63
Free Cash Flow Per Share
-1.84 -5.31 -8.35 -9.10 -8.07
CapEx Per Share
0.09 0.02 0.04 0.26 0.44
Free Cash Flow to Operating Cash Flow
1.05 1.00 1.01 1.03 1.06
Dividend Paid and CapEx Coverage Ratio
-19.48 -214.57 -191.38 -34.21 -17.23
Capital Expenditure Coverage Ratio
-19.48 -214.57 -191.38 -34.21 -17.23
Operating Cash Flow Coverage Ratio
-0.13 -0.36 -0.73 -0.98 -3.98
Operating Cash Flow to Sales Ratio
-0.16 -0.84 -1.75 -9.69 -53.70
Free Cash Flow Yield
-0.92%-4.00%-7.32%-7.98%-6.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-52.10 -20.36 -13.32 -10.97 -16.89
Price-to-Sales (P/S) Ratio
18.81 21.17 24.05 124.97 833.09
Price-to-Book (P/B) Ratio
-69.72 -72.81 -44.02 24.28 7.33
Price-to-Free Cash Flow (P/FCF) Ratio
-108.41 -25.02 -13.65 -12.54 -14.66
Price-to-Operating Cash Flow Ratio
-113.77 -25.14 -13.72 -12.90 -15.51
Price-to-Earnings Growth (PEG) Ratio
-3.44 0.86 0.75 -0.23 1.09
Price-to-Fair Value
-69.72 -72.81 -44.02 24.28 7.33
Enterprise Value Multiple
-93.37 -27.56 -16.21 -11.62 -14.49
Enterprise Value
12.43B 7.99B 6.67B 6.46B 6.14B
EV to EBITDA
-93.37 -27.56 -16.21 -11.62 -14.49
EV to Sales
19.23 21.98 24.99 126.22 789.21
EV to Free Cash Flow
-110.86 -25.99 -14.19 -12.66 -13.89
EV to Operating Cash Flow
-116.55 -26.11 -14.26 -13.03 -14.70
Tangible Book Value Per Share
-2.92 -1.90 -2.67 4.61 16.04
Shareholders’ Equity Per Share
-2.85 -1.83 -2.59 4.70 16.13
Tax and Other Ratios
Effective Tax Rate
-0.04 -0.01 -0.02 >-0.01 <0.01
Revenue Per Share
10.60 6.28 4.74 0.91 0.14
Net Income Per Share
-3.82 -6.53 -8.55 -10.40 -7.00
Tax Burden
1.04 1.01 1.02 1.01 1.00
Interest Burden
1.48 1.21 1.10 1.06 1.01
Research & Development to Revenue
0.47 0.84 1.55 7.42 38.04
SG&A to Revenue
0.43 0.78 0.97 0.00 0.00
Stock-Based Compensation to Revenue
0.17 0.26 0.25 1.25 8.59
Income Quality
0.46 0.81 0.97 0.85 1.09
Currency in EUR